Medigus Ltd. (MDGS)

[Crazy Money]

Need SMART MONEY to make this run... weee

[Crazy Money]

Go up

[whytestocks]

BREAKING NEWS: $MDGS Medigus: ScoutCam Announces Success of HD Micro Video Camera in NASA's Robotic Refueling Mission 3

Use of micro ScoutCam 8.0 HD marks the customized visual solutions leader’s second in-flight achievement with the U.S. space agency OMER, Israel, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq:MDGS) (TASE:MDGS) ,  a technology company engaged in advanced medi...

Find out more MDGS - Medigus: ScoutCam Announces Success of HD Micro Video Camera in NASA's Robotic Refueling Mission 3

[MacBoys]

Oct. 23, 2020 8:18 AM ETMedigus Ltd. (MDGS)By: Gaurav Batavia, SA News Editor
Medigus’ (NASDAQ:MDGS) +27% subsidiary ScoutCam announces the success of its micro ScoutCam 8.0 HD in NASA’s third Robotic Refueling Mission, which was officially used in-orbit on October 19th-22st, 2020.
Custom-developed for NASA between 2015 and 2016, micro ScoutCam 8.0 HD features one module consisting of HD camera and illumination.
The second phase of the Robotic Refueling Mission utilized micro ScoutCam 1.2, the first generation of the company’s minuscule video camera.
Source

[MacBoys]

Medigus: ScoutCam Announces Success of HD Micro Video Camera in NASA’s Robotic Refueling Mission 3

[MacBoys]

Some decent pre-market action. Hopefully an indication for a Friday run

[Nfixus]

Medigus Stock Doubles in no Time: Time to Sell or Hold?

https://pennystocks.news/medigus-stock-doubles-in-no-time-time-to-sell-or-hold-mdgs/

[whytestocks]

Just In: $MDGS Medigus to Take a Controlling Interest in Leading Internet Company Gix

Medigus will hold approximately 33% of Gix Internet which finished Q2 of 2020 with $18.5 million in revenues. OMER, Israel, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS) , a technology company engaged in advanced medical solutions and innovative in...

Find out more MDGS - Medigus to Take a Controlling Interest in Leading Internet Company Gix

[ClayTrader]

* * $MDGS Video Chart 10-13-2020 * *

Link to Video - click here to watch the technical chart video

[bleu22]

Out $3.80, back in $3.07, let’s see... Tons of volume here... GLTA

[jchords]

Anyone know details for the warrants?

[FROZENFLAME]

Out at $3.85 moving money to $ EARS$

[dawood]

I got out at 3.22 from 1.93. Good luck!

[FROZENFLAME]

Looking good $$$

[FROZENFLAME]

$TLC my only COVID play, waiting for news .

[whytestocks]

Just In: $MDGS 4 Penny Stocks To Watch Today As Biotech Stocks Boost Market Gains

Are These Biotech Penny Stocks On Your Watch List Today? One of the most active industries right now is biotech & penny stocks have stood to benefit the most. Quite honestly, when you think about “novel” treatments, you’re talking about early-stage compa...

Read the whole news MDGS - 4 Penny Stocks To Watch Today As Biotech Stocks Boost Market Gains

[whytestocks]

JUST IN: $MDGS Medigus: Smart Repair Pro gains Amazon's approval for launch in the UK and 4 top EU countries

OMER, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS) , a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it was informed by Smart Repair Pro, Inc. a data-driven e-commerce company opera...

Read the whole news MDGS - Medigus: Smart Repair Pro gains Amazon's approval for launch in the UK and 4 top EU countries

[otcmoneydoubler]

LOL. HALB LOOKS LIKE THE NEW SHERIFF IN TOWN ON COVID ANTIBODY NEWS.

[FROZENFLAME]

Should open around $5s

[FROZENFLAME]

7M float SQUEEZE TO THE MOOOOOON

[otcmoneydoubler]

LOOKS LIKE MDGS AND PECK WILL BE THE MEGA RUNNERS FOR TODAY

[FROZENFLAME]

Nice $3+ already, news out $$$

[ClayTrader]

* * $MDGS Video Chart 10-09-2020 * *

Link to Video - click here to watch the technical chart video

[KOmani]

Taking $0.10 swings isn't exactly fun ... have to use stops more often these days.

[whytestocks]

Breaking News: $MDGS Are These Penny Stocks Set For New Highs Today? 5 To Watch

Are These Premarket Penny Stocks On Your Watch List Today? If you’re looking for trending penny stocks right now, Friday’s premarket is chock full. There are trends coming from all different industries today. One of the driving forces right now hinges on stimulus h...

In case you are interested MDGS - Are These Penny Stocks Set For New Highs Today? 5 To Watch

[FROZENFLAME]

7M float, $3+ very possible .

[FROZENFLAME]

Agree, it should run back up now with new highs .

[whytestocks]

JUST IN: $MDGS Medigus Enters E-Commerce Brands Marketing on Amazon Marketplace

Medigus Signs a definitive agreement to acquire a controlling interest of two companies which operate as sellers of three brands on Amazon Marketplace OMER, Israel, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS) , MDGS), a technology company engaged...

Find out more MDGS - Medigus Enters E-Commerce Brands Marketing on Amazon Marketplace

[KOmani]

$1.80 seems like support ... for now.

[FROZENFLAME]

Adding the dip .

[FROZENFLAME]

I think most people sell on the news out by now, GO TIME .

[FROZENFLAME]

SQUEEZE $$$$

[whytestocks]

NEWS: $MDGS Medigus to Enter Online Brands Marketing on Amazon Marketplace

Medigus Signs a non-binding letter of intent to acquire a controlling interest of two companies which operate as sellers of three brands on Amazon Marketplace  OMER, Israel, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS) , a technology company develop...

In case you are interested MDGS - Medigus to Enter Online Brands Marketing on Amazon Marketplace

[whytestocks]

News: $MDGS Medigus: ScoutCam Announced Acceptance of $2.4M Quote from a Fortune 500 Multinational Healthcare Corporation

Following Acceptance of $2.4M Quote, Preeminent Visual Solutions Creator will Develop Customized Products for Medical Supplies Giant OMER, Israel, July 24, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS) , a technology company developing minimally invasive tools and an ...

Find out more MDGS - Medigus: ScoutCam Announced Acceptance of $2.4M Quote from a Fortune 500 Multinational Healthcare Corporation

[StockPicker999]

Some big news from Medigus:
https://talkmarkets.com/content/stocks--equities/medigus-is-facing-multiple-opportunities-but-is-not-without-risk?post=267656

Really impressed with all these developments. What do you think?

[StockPicker999]

Some big news from Medigus:
https://talkmarkets.com/content/stocks--equities/medigus-is-facing-multiple-opportunities-but-is-not-without-risk?post=267656

Really impressed with all these developments. What do you think?

[StockPicker999]

Some big news from Medigus:
https://talkmarkets.com/content/stocks--equities/medigus-is-facing-multiple-opportunities-but-is-not-without-risk?post=267656

Really impressed with all these developments. What do you think?

[midastouch017]

Medigus inks license deal with Polyrizon

Jul. 17, 2020 7:48 AM ET|About: Medigus Ltd. (MDGS)|By: Mamta Mayani, SA News Editor

Medigus (NASDAQ:MDGS) jumps 28% premarket after signing an investment and a reseller agreement with privately held, Polyrizon Ltd.

As part of the reseller agreement, Medigus receives an exclusive global license to resell the Polyrizon products, focusing on a unique Biogel for the protection from COVID-19. The term of the license will be for four years.

In consideration, Polyrizon will receive annual royalty payments equal to 10% of Medigus annualized operating profit arising from the sale of the products.

In addition, Medigus and Polyrizon also signed an ordinary share purchase agreement, including an investment of $10,000 and a loan of $94,000 which will be extended to Polyrizon. As such, Medigus will be issued shares representing 19.9% of outstanding share capital of Polyrizon.

Also, Medigus was granted the option to invest an additional $1M in consideration for Polyrizon shares, after which prior will own 51% of Polyrizon on a fully diluted basis. The options is exercisable until April 23, 2023.

[midastouch017]

Medigus to Resell Polyrizon’s Future Products for Protection Against COVID-19 Spread and Other Biological Threats

GlobeNewswire GlobeNewswire•July 17, 2020

The companies signed investment and reseller agreements for joint commercialization

OMER, Israel, July 17, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced the signing of an investment agreement and a reseller agreement with Polyrizon Ltd., a private company engaged in developing biological gels for the purpose of protecting patients against biological threats.

As part of the reseller agreement Medigus receives an exclusive global license to resell the Polyrizon products, focusing on a unique Biogel for the protection from COVID-19 virus. The term of the license will be for four years, commencing upon receipt of sufficient FDA approvals for the lawful marketing and sale of the products globally. Medigus shall have the right to purchase the Polyrizon products on a cost plus 15% basis for the purpose of reselling the products worldwide. In consideration for the license, Polyrizon shall be entitled to receive annual royalty payments equal to 10% of Medigus annualized operating profit arising from the sale of the products.

Polyrizon develops highly differentiated biological gels to protect patients against biological threats and external pathogens. Future products will exploit Polyrizon’s Capture & Contain platform Technology to safely prevent allergens & virus intrusions through the upper airways and eye cavities.

In addition, Medigus and Polyrizon signed an ordinary share purchase agreement. The agreement includes investment of $10,000 and a loan of $94,000 that will be extended to Polyrizon. As such, Medigus will be issued shares representing 19.9% of the issued and outstanding share capital of Polyrizon, on a fully diluted basis excluding outstanding deferred shares. In addition, Medigus was granted the option, exercisable at its sole discretion, to invest an additional investment amount of US$1,000,000, in consideration for shares of Polyrizon such that following the additional investment, Medigus will own 51% of Polyrizon on a fully diluted basis excluding outstanding deferred shares. The options is exercisable until the earlier of April 23, 2023 or the consummation by Polyrizon of equity financing of at least US$500,000 based on a pre-money valuation of at least US$10,000,000.

Polyrizon’s products are meant to mitigate biological threats such as SARS-CoV-2, COVID-19, bacteria and more by providing protection from the spread and contamination of Coronavirus inhaled through the upper airways and eyes, using spray or eyedrops made of mucoadhesive biological gel (a gel that contains covalently bound specific Abs against SARS-CoV-2 specific surface proteins) aiming to lower the intrusion levels of the virus through the nasal and buccal cavities for several hours. Similarly, the products may provide protection from airborne allergens through the upper airways and eyes, reducing the allergic reaction due to a lower amount of allergens reaching its target cells.

About Medigus

Medigus is traded on the Nasdaq Capital Market and the TASE (Tel Aviv Stock Exchange). To learn more about the company’s advanced technology, please visit www.medigus.com.

https://finance.yahoo.com/news/medigus-resell-polyrizon-future-products-113010684.html

[midastouch017]

GERD IP, A Subsidiary of Medigus, Files Complaint with Delaware District Court Alleging Infringement of two Proprietary Patents

Published: July 12, 2020 at 11:30 p.m. ET

OMER, Israel, Jul 13, 2020 (GLOBE NEWSWIRE via COMTEX) -- OMER, Israel, July 13, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that GERD IP, Inc., a Delaware corporation and majority owned subsidiary of Medigus, filed a complaint with the United States District Court for the District of Delaware, alleging infringement of two of GERD IP's proprietary patents. The infringement complaint was brought against an active company in the field of medical devices.

The claim for patent infringement refers to two patents issued by the United States Patent and Trademark Office, owned by GERD IP, Inc. In its complaint, GERD IP requested a trial by jury based on the assertion that the defendant has and continues to directly infringe the company's patents by making, using, testing, selling, offering for sale or importing into the United States products and services covered by GERD IP's patents.

The technology underlying the allegedly infringed patents serves as the foundation of a device used to perform a minimally invasive, trans-oral fundoplication surgical procedure for the treatment of patients suffering from Gastroesophageal Reflux Disease.

https://www.marketwatch.com/press-release/gerd-ip-a-subsidiary-of-medigus-files-complaint-with-delaware-district-court-alleging-infringement-of-two-proprietary-patents-2020-07-13-71843027?tesla=y

[midastouch017]

MDGS / Medigus Ltd. - Institutional Ownership and Shareholders

https://fintel.io/so/us/mdgs

[midastouch017]

Medigus Increases Holdings in ScoutCam

Published: June 24, 2020 at 8:00 a.m. ET

The Company Increased its Ownership in ScoutCam to 50.1% Following the Conversion of Credit into Equity


OMER, Israel, June 24, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that it was issued additional shares of common stock and warrants in ScoutCam (OTC:SCTC), the Company's subsidiary and a leading developer and manufacturer of customized visual solutions and supplementary technologies, following the conversion of outstanding credit in the amount of $381,136. Following the conversion, the Company now holds 50.1% in ScoutCam.

This conversion follows a recent investment of two million dollars in ScoutCam by Mori Arkin, a prominent life sciences and pharmaceuticals entrepreneur.

"As we continue to witness ScoutCam's great potential, we strongly believe it's in Medigus's best interest to maintain our majority stake. During recent months, ScoutCam has engaged lucrative new customers, strengthened its IP and revealed new and exciting developments to the public." said Liron Carmel, CEO of Medigus.

ScoutCam is a leading provider of customized visual solutions for organizations across a variety of industries in the form of highly resistant micro cameras and supplementary technologies. ScoutCam devices are used across the medical, aerospace, industrial, research and defense industries.

https://finance.yahoo.com/news/medigus-increases-holdings-scoutcam-110010501.html

[midastouch017]

Medigus: ScoutCam Granted Canadian Patent for New Endoscope Irrigation Technology

GlobeNewswire GlobeNewswire•June 12, 2020

ScoutCam’s Healthcare Technology Further Showcases Company’s Environmentally Resistant & Durable Cameras

OMER, Israel, June 12, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (MDGS) (MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that ScoutCam Ltd, wholly owned subsidiary of ScoutCam Inc. (SCTC), the Company’s indirect subsidiary and a leading developer and manufacturer of customized visual solutions and supplementary technologies, was granted a patent in Canada for its endoscope irrigation technology. The patented technology, which has already been approved for patents in other jurisdictions, including the United States, European Union, and Japan, showcases the resistance and durability of ScoutCam’s micro-cameras as well as the Company's ability to reduce the diameter of its devices compared with competing endoscopes/borescopes with traditional irrigation technology, further positioning ScoutCam as a leader in the medical, industrial and aeronautic/defense sectors.

The patent features ScoutCam’s micro-ScoutCam, which has been integrated into medical endoscope devices in an effort to make endoscopies less invasive and thereby contributing to the evolution of the healthcare industry. The technology covered in the patent allows adding irrigation to an endoscope without the need for an additional tube dedicated for fluids. The innovative offering saves space within the tube by unifying the water with other channels within the endoscope, which allows ScoutCam to design and manufacture an endoscope with irrigation smaller in diameter than competing devices, while using the same sensors.

“The smaller the endoscope diameter, the more pathologies it can help detect and help treat,” said Yaron Silberman, Chief Executive Officer of ScoutCam. “ScoutCam’s patented irrigation technology not only reduces the device diameter, but also increases the ability to see in various anatomical parts and can streamline the endoscopic process.”

In order to implement the patented technology, ScoutCam cameras are embedded in the space where water flows freely, further proving that its cameras are waterproof and resistant to damage in various environmental conditions. This patent-protected technology has previously been used in a therapeutic endoscope that was cleared for marketing by the U.S. Food and Drug Administration.

https://finance.yahoo.com/news/medigus-scoutcam-granted-canadian-patent-130010895.html

[midastouch017]

Kudos ib12u! Nicely done!

[ib12u]

LOL Looks like Lightening struck Twice here!! Just as I predicted! And yet again I bagged! LOL!!! Though not as big as the previous one, it's none the less a BAG! LOL!

Welp! that's it for me for now, looks like this will be turning a corner in the next few days so I'll be holding off short plays until this peaks out again!

BUT WOW!! I never knew Bear-Plays could be so profitable!

What the hell was I thinking all these years with only Bull-Plays!

There's BEARS in them-thar-hills!!

[ib12u]

TRUE! But Lightening "ALWAYS" Strikes Twice with Stocks! Which is why their chart patterns look as they do!

While again, I was very lucky to have fat-fingered a short-position here and it then tanked to about a buck where I covered and bagged, it was an accident that forever changed by game plans!

Now, I'm quite curious!

My panic-cover may not've been warranted! Whereas this still haven't increased since my short was covered!

It actually fell a lil-lower!



And given the way the chart is trending, I just might be on to something here with my new game plan!

Hmmmmmm.


We'll see even more "TODAY" after the opening bell!

But I'll most certainly know by next week's trends!

This is getting exciting!

[midastouch017]

I'm testing a Short Position except this time it's intended.

Lightning never strikes the same place twice

GLTY

[ib12u]

well, I'm testing a Short Position except this time it's intended. I made bag on my last accidental short position, but looks like this will be tanking further so I'm testing the bear-side of the stock this time ;) But I'm treading carefully just in case this runs up without warning :-}

[ib12u]

WHEW!!!! I got in this @ $3.43 and All along I was watching for an up-tick but felt suckered when this insatead sanked to almost a buck. ONLY TO THEN LOOK AT MY POSITION AND SAW I WAS IN A SHORT POSITIPON! "WTF?"

Some how I fat Fiingered myself into a Short Position! WOW!!!

NEVER BUY SHARES WHILE HALF-SLEEP THEN DOSE OFF INTO A COMA!



So Technically when this Tanked I went UP in Profit! I Didnt even know this! I thought I was in the Red!


But here it is several days later and to my surprise my unintended short position actually gave me GOOD BAG! WOW!

Even though I Quickly Covered my short and Made a Decent Bag, This was a very very VERY Dangerouse Move!

Hell, like, This gem could've just as well shot to the moon without my knowing and my short position would've needed a Mortage to Cover it! WHEW!!

I will never as in NEVER EVER Do that again! Hell to the Mother-Flipping NO!

I Lucked my "ASK" out on this one! Really Really Lucky!

MDGS ??!!! Thanks for the TANK! You made me BIG BANK! LOL!

[midastouch017]

What’s it going to take to move this one?!?!?!

A substantial $$$ value contract,
certainly not a half fluff PR like
the one issued today.